KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) FCF Margin (2016 - 2025)

Historic FCF Margin for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to 48.44%.

  • Pacific Biosciences Of California's FCF Margin rose 633400.0% to 48.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 81.68%, marking a year-over-year increase of 566800.0%. This contributed to the annual value of 137.81% for FY2024, which is 41500.0% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its FCF Margin stood at 48.44% for Q3 2025, which was up 633400.0% from 75.26% recorded in Q2 2025.
  • Pacific Biosciences Of California's FCF Margin's 5-year high stood at 48.44% during Q3 2025, with a 5-year trough of 252.99% in Q1 2023.
  • Its 5-year average for FCF Margin is 136.73%, with a median of 118.53% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -5634700bps in 2021, then surged by 1372500bps in 2023.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's FCF Margin stood at 95.92% in 2021, then crashed by -150bps to 239.35% in 2022, then surged by 57bps to 102.1% in 2023, then rose by 19bps to 82.26% in 2024, then surged by 41bps to 48.44% in 2025.
  • Its last three reported values are 48.44% in Q3 2025, 75.26% for Q2 2025, and 122.32% during Q1 2025.